TBProfiler v6.6.0
Change
Important
This version update changes the implementation of the epistais rule which may change the resistance predictions for bedaquile, clofazimine and kanamycin. Resistance is new reported unless an abrogating variant is completely fixed (100% frequency in reads). If frequency is 10% than the frequency of the abriogating variant, a note is made indicating that the episatis rule may not apply.
- Updated system for providing epistasis rules
- Add generic profile plugin
- Update conda file
- Updated the default docx template
- Add software and versions to output